| Deler fremragende | 4,022,143 shares |
| Insideraktier | 505.883 shares |
| Insider ejerskab | 12,58 % |
| Total Insiders | 13 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Dermata Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Maria E Bedoya-Toro SVP, Regulatory Affairs - [O] | 1.012 | 1.012 | |
| Brittany Bradrick Director - [D] | 23.443 | 1.715 | |
| Mary Fisher Director - [D] | 196.946 | 19.695 | |
| David F Hale Director - [D] | 81.469 | 8.147 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Thomas Insley Chief Financial Officer - [O] | 14.337 | 1.049 | |
| Steven J Mento | 5.000 | ||
| Nardo Christopher J. Senior VP, Development - [O] | 2.439 | 178 | |
|
Gerald T Proehl
PRESIDENT, CHAIRMAN, CEO, Director, 10% Owner -
[D]
[O]
|
122.563 | 122.563 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
|
Proehl Investment Ventures LLC
10% Owner -
|
2.905.544 | 212.601 | |
| Andrew Seth Sandler Director - [D] | 24.184 | 1.770 | |
| Scott Kathleen D. Director - [D] | 29.584 | 2.165 | |
| Van Hoose Kyri K. SVP, CFO - [O] | 130.423 | 130.423 | |
| Wendell Wierenga Director - [D] | 62.398 | 4.566 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i DRMA / Dermata Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i DRMA / Dermata Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-17 | 2026-02-17 | 4 | Bedoya-Toro Maria E | DRMA | Common Stock | D | 1,2700 | 1.000 | 1 | 1.012 | ||||
| 2025-12-29 | 2025-12-23 | 4 | Van Hoose Kyri K. | DRMA | Common Stock | D | 122.549 | 130.423 | ||||||
| 2025-12-29 | 2025-12-23 | 4 | PROEHL GERALD T By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020 | DRMA | Common Stock | I | 122.549 | 122.563 | ||||||
| 2025-12-29 | 2025-12-23 | 4 | PROEHL GERALD T By Proehl Family Trust | DRMA | Common Stock | I | 490.196 | 490.255 | ||||||
| 2025-01-23 | 2025-01-21 | 4 | FISHER MARY | DRMA | Common Stock | D | 196.851 | 196.946 | ||||||
| 2025-01-23 | 2025-01-21 | 4 | Van Hoose Kyri K. | DRMA | Common Stock | D | 78.741 | 78.741 | ||||||
| 2025-01-23 | 2025-01-21 | 4 | PROEHL GERALD T By Proehl Investment Ventures LLC | DRMA | Common Stock | I | 787.402 | 799.508 | ||||||
| 2025-01-23 | 2025-01-23 | 4 | HALE DAVID F By Hale BioPharma Ventures LLC | DRMA | Common Stock | I | 78.741 | 80.957 | ||||||
| 2022-10-07 | 2022-10-06 | 4 | Scott Kathleen D. | DRMA | Common Stock | D | 11.359 | 27.145 | ||||||
| 2022-10-07 | 2022-10-06 | 4 | FISHER MARY | DRMA | Common Stock | D | 9.810 | 23.443 | ||||||
| 2022-10-07 | 2022-10-06 | 4 | Bradrick Brittany | DRMA | Common Stock | D | 9.810 | 23.443 | ||||||
| 2022-10-07 | 2022-10-06 | 4 | HALE DAVID F | DRMA | Common Stock | D | 30.155 | 75.720 | ||||||
| 2022-10-07 | 2022-10-06 | 4 | Sandler Andrew Seth | DRMA | Common Stock | D | 10.120 | 24.184 | ||||||
| 2022-10-07 | 2022-10-06 | 4 | WIERENGA WENDELL | DRMA | Common Stock | D | 20.654 | 62.398 | ||||||
| 2022-07-08 | 2022-07-07 | 4 | Scott Kathleen D. | DRMA | Common Stock | D | 9.960 | 15.786 | ||||||
| 2022-07-08 | 2022-07-07 | 4 | FISHER MARY | DRMA | Common Stock | D | 8.602 | 13.633 | ||||||
| 2022-07-08 | 2022-07-07 | 4 | WIERENGA WENDELL | DRMA | Common Stock | D | 18.110 | 41.744 | ||||||
| 2022-07-08 | 2022-07-07 | 4 | HALE DAVID F | DRMA | Common Stock | D | 26.441 | 45.565 | ||||||
| 2022-07-08 | 2022-07-07 | 4 | Bradrick Brittany | DRMA | Common Stock, par value $0.0001 per share | D | 8.602 | 13.633 | ||||||
| 2022-07-08 | 2022-07-07 | 4 | Sandler Andrew Seth | DRMA | Common Stock, par value $0.0001 per share | D | 8.874 | 14.064 | ||||||
| 2022-04-08 | 2022-04-07 | 4 | WIERENGA WENDELL | DRMA | Common Stock | D | 10.593 | 15.471 | ||||||
| 2022-04-08 | 2022-04-07 | 4 | FISHER MARY | DRMA | Common Stock | D | 5.031 | 5.031 | ||||||
| 2022-04-08 | 2022-04-07 | 4 | Scott Kathleen D. | DRMA | Common Stock | D | 5.826 | 5.826 | ||||||
| 2022-04-08 | 2022-04-07 | 4 | Sandler Andrew Seth | DRMA | Common Stock, par value $0.0001 per share | D | 5.190 | 5.190 | ||||||
| 2022-04-08 | 2022-04-07 | 4 | Bradrick Brittany | DRMA | Common Stock, par value $0.0001 per share | D | 5.031 | 5.031 | ||||||
| 2022-04-08 | 2022-04-07 | 4 | HALE DAVID F | DRMA | Common Stock | D | 15.466 | 19.124 | ||||||
| 2022-01-14 | 2022-01-12 | 4 | Bradrick Brittany | DRMA | Stock Option (right to Buy) | D | 1,50 | 10.000 | 10.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Sandler Andrew Seth | DRMA | Stock Option (right to buy) | D | 1,88 | 5.000 | 5.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Nardo Christopher J. | DRMA | Stock Option (right to buy) | D | 1,88 | 30.000 | 30.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Van Hoose Kyri K. | DRMA | Stock Option (right to buy) | D | 1,88 | 30.000 | 30.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | WIERENGA WENDELL | DRMA | Stock Option (right to buy) | D | 1,88 | 5.000 | 5.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | HALE DAVID F | DRMA | Stock Option (right to buy) | D | 1,88 | 5.000 | 5.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Scott Kathleen D. | DRMA | Stock Option (right to buy) | D | 1,88 | 5.000 | 5.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Mento Steven J | DRMA | Stock Option (right to Buy) | D | 1,88 | 5.000 | 5.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | FISHER MARY | DRMA | Stock Option (right to buy) | D | 1,88 | 5.000 | 5.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Bedoya-Toro Maria E | DRMA | Stock Option (right to buy) | D | 1,88 | 15.000 | 15.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | PROEHL GERALD T | DRMA | Stock Option (right to buy) | D | 1,88 | 57.859 | 57.859 | |||||
| 2022-01-05 | 2022-01-03 | 4 | PROEHL GERALD T | DRMA | Stock Option (right to buy) | D | 2,07 | 42.141 | 42.141 | |||||
| 2022-01-05 | 2022-01-03 | 4 | PROEHL GERALD T | DRMA | Stock Option (right to buy) | D | 2,07 | 4.517 | 4.517 | |||||
| 2022-01-05 | 2022-01-03 | 4 | PROEHL GERALD T | DRMA | Stock Option (right to buy) | D | 1,88 | 197.610 | 197.610 | |||||
| 2021-11-26 | 2021-11-23 | 4 | PROEHL GERALD T | DRMA | Common Stock | D | 2,4000 | 20.000 | 48 | 59.512 | ||||
| 2021-09-01 | 2021-09-01 | 4 | Van Hoose Kyri K. | DRMA | Stock Option (right to Buy) | D | 5,39 | 75.000 | 75.000 | |||||
| 2021-08-17 | 2021-08-17 | 4 | Mento Steven J | DRMA | Stock Option (right to Buy) | D | 7,00 | 10.000 | 10.000 | |||||
| 2021-08-17 | 2021-08-17 | 4 | Bedoya-Toro Maria E By Munera Family Trust | DRMA | Warrant to Purchase Common Stock | I | 20,50 | 4.878 | 4.878 | |||||
| 2021-08-17 | 2021-08-17 | 4 | Bedoya-Toro Maria E By Munera Family Trust | DRMA | Series 1b Preferred Stock | I | -100.000 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Bedoya-Toro Maria E By Munera Family Trust | DRMA | Series 1a Warrants | I | -100.000 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Bedoya-Toro Maria E By Munera Family Trust | DRMA | Series 1 Preferred Stock | I | -280.000 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Bedoya-Toro Maria E By Munera Family Trust | DRMA | Series 1c Preferred Stock | I | -357.142 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Bedoya-Toro Maria E By Munera Family Trust | DRMA | Series 1a Preferred Stock | I | -400.000 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Bedoya-Toro Maria E By Munera Family Trust | DRMA | Series 1d Preferred Stock | I | -61.821 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Bedoya-Toro Maria E By Munera Family Trust | DRMA | Common Stock | I | 13.658 | 84.143 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Bedoya-Toro Maria E By Munera Family Trust | DRMA | Common Stock | I | 17.421 | 70.485 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Bedoya-Toro Maria E By Munera Family Trust | DRMA | Common Stock | I | 4.878 | 53.064 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Bedoya-Toro Maria E By Munera Family Trust | DRMA | Common Stock | I | 19.512 | 48.186 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Bedoya-Toro Maria E By Munera Family Trust | DRMA | Common Stock | I | 9.162 | 28.674 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | HALE DAVID F By Hale Family Trust | DRMA | Warrant to Purchase Common Stock | I | 7,00 | 35.714 | 35.714 | |||||
| 2021-08-17 | 2021-08-17 | 4 | HALE DAVID F By Hale BioVentures LLC | DRMA | Warrant to Purchase Common Stock | I | 20,50 | 3.048 | 3.048 | |||||
| 2021-08-17 | 2021-08-17 | 4 | HALE DAVID F By Hale BioVentures LLC | DRMA | Series 1a Warrants | I | -62.500 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | HALE DAVID F By Hale BioVentures LLC | DRMA | Series 1 Preferred Stock | I | -555.622 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | HALE DAVID F By Hale BioVentures LLC | DRMA | Series 1c Preferred Stock | I | -3.571.428 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | HALE DAVID F By Hale BioVentures LLC | DRMA | Series 1b Preferred Stock | I | -410.000 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | HALE DAVID F By Hale BioVentures LLC | DRMA | Series 1a Preferred Stock | I | -250.000 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | HALE DAVID F By Hale BioVentures LLC | DRMA | Series 1d Preferred Stock | I | -302.112 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | HALE DAVID F By Hale Family Trust | DRMA | Common Stock | I | 35.714 | 35.714 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | HALE DAVID F By Hale BioVentures LLC | DRMA | Common Stock | I | 27.103 | 532.925 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | HALE DAVID F By Hale BioVentures LLC | DRMA | Common Stock | I | 174.216 | 505.822 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | HALE DAVID F By Hale BioVentures LLC | DRMA | Common Stock | I | 20.000 | 331.606 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | HALE DAVID F By Hale BioVentures LLC | DRMA | Common Stock | I | 12.195 | 311.606 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | HALE DAVID F By Hale BioVentures LLC | DRMA | Common Stock | I | 44.777 | 299.411 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Proehl Investment Ventures LLC | DRMA | Warrant to Purchase Common Stock | D | 20,50 | 27.987 | 27.987 | |||||
| 2021-08-17 | 2021-08-17 | 4 | Proehl Investment Ventures LLC | DRMA | Series 1a Warrants | D | -573.750 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Proehl Investment Ventures LLC | DRMA | Series 1 Preferred Stock | D | -1.755.622 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Proehl Investment Ventures LLC | DRMA | Series 1c Preferred Stock | D | -25.582.050 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Proehl Investment Ventures LLC | DRMA | Series 1b Preferred Stock | D | -3.722.500 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Proehl Investment Ventures LLC | DRMA | Series 1a Preferred Stock | D | -2.295.000 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Proehl Investment Ventures LLC | DRMA | Series 1d Preferred Stock | D | -2.436.657 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Proehl Investment Ventures LLC | DRMA | Common Stock | D | 85.640 | 2.905.544 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Proehl Investment Ventures LLC | DRMA | Common Stock | D | 1.247.904 | 2.819.904 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Proehl Investment Ventures LLC | DRMA | Common Stock | D | 181.585 | 1.572.000 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Proehl Investment Ventures LLC | DRMA | Common Stock | D | 111.951 | 1.390.415 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Proehl Investment Ventures LLC | DRMA | Common Stock | D | 361.147 | 1.278.464 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Scott Kathleen D. | DRMA | Stock Option (right to Buy) | D | 7,00 | 10.000 | 10.000 | |||||
| 2021-08-17 | 2021-08-17 | 4 | WIERENGA WENDELL | DRMA | Series 1d Preferred Stock | D | -55.078 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | WIERENGA WENDELL | DRMA | Common Stock | D | 8.163 | 13.041 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Sandler Andrew Seth | DRMA | Stock Option (right to Buy) | D | 7,00 | 10.000 | 10.000 | |||||
| 2021-08-17 | 2021-08-17 | 4 | FISHER MARY | DRMA | Stock Option (right to Buy) | D | 7,00 | 10.000 | 10.000 | |||||
| 2021-08-17 | 2021-08-17 | 4 | INSLEY THOMAS By Insley Family Trust | DRMA | Series 1d Preferred Stock | I | -30.910 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | INSLEY THOMAS By Insley Family Trust | DRMA | Common Stock | I | 4.581 | 14.337 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Nardo Christopher J. By Nardo Family Trust Dated October 3, 2001 | DRMA | Series 1 Preferred Stock | I | -50.000 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | Nardo Christopher J. By Nardo Family Trust Dated October 3, 2001 | DRMA | Common Stock | I | 2.439 | 2.439 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | PROEHL GERALD T By Proehl Family Trust | DRMA | Warrant to Purchase Common Stock | I | 7,00 | 142.857 | 142.857 | |||||
| 2021-08-17 | 2021-08-17 | 4 | PROEHL GERALD T By Proehl Investment Ventures LLC | DRMA | Warrant to Purchase Common Stock | I | 20,50 | 27.987 | 27.987 | |||||
| 2021-08-17 | 2021-08-17 | 4 | PROEHL GERALD T By Proehl Investment Ventures LLC | DRMA | Series 1a Warrants | I | -573.750 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | PROEHL GERALD T By Proehl Investment Ventures LLC | DRMA | Series 1 Preferred Stock | I | -1.755.622 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | PROEHL GERALD T By Proehl Investment Ventures LLC | DRMA | Series 1c Preferred Stock | I | -25.582.050 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | PROEHL GERALD T By Proehl Investment Ventures LLC | DRMA | Series 1b Preferred Stock | I | -3.722.500 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | PROEHL GERALD T By Proehl Investment Ventures LLC | DRMA | Series 1a Preferred Stock | I | -2.295.000 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | PROEHL GERALD T By Proehl Investment Ventures LLC | DRMA | Series 1d Preferred Stock | I | -2.436.657 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | PROEHL GERALD T By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020 | DRMA | Series 1d Preferred Stock | I | -241.325 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | PROEHL GERALD T By Meghan Proehl Wilder 2020 Irrevocable Trust | DRMA | Series 1d Preferred Stock | I | -60.240 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | PROEHL GERALD T By Allison Taylor Proehl 2020 Irrevocable Trust | DRMA | Series 1d Preferred Stock | I | -120.481 | 0 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | PROEHL GERALD T By Proehl Family Trust | DRMA | Common Stock | I | 142.857 | 152.857 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | PROEHL GERALD T By Proehl Investment Ventures LLC | DRMA | Common Stock | I | 85.640 | 2.905.544 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | PROEHL GERALD T By Proehl Investment Ventures LLC | DRMA | Common Stock | I | 1.247.904 | 2.819.904 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | PROEHL GERALD T By Proehl Investment Ventures LLC | DRMA | Common Stock | I | 181.585 | 1.572.000 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | PROEHL GERALD T By Proehl Investment Ventures LLC | DRMA | Common Stock | I | 111.951 | 1.390.415 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | PROEHL GERALD T By Proehl Investment Ventures LLC | DRMA | Common Stock | I | 361.147 | 1.278.464 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | PROEHL GERALD T By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020 | DRMA | Common Stock | I | 35.767 | 35.767 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | PROEHL GERALD T By Meghan Proehl Wilder 2020 Irrevocable Trust | DRMA | Common Stock | I | 8.928 | 8.928 | ||||||
| 2021-08-17 | 2021-08-17 | 4 | PROEHL GERALD T By Allison Taylor Proehl 2020 Irrevocable Trust | DRMA | Common Stock | I | 17.857 | 17.857 | ||||||
| 2021-08-17 | 2021-08-16 | 4 | PROEHL GERALD T By Proehl Family Trust | DRMA | Common Stock | I | 4,9631 | 10.000 | 50 | 10.000 | ||||
| 2021-08-12 | 3 | Scott Kathleen D. By Scott 2008 Trust Dated 3/28/08 | DRMA | Common Stock | I | 2.439 | ||||||||
| 2021-08-12 | 3 | Bedoya-Toro Maria E | DRMA | Common Stock | D | 30.487 | ||||||||
| 2021-08-12 | 3 | Bedoya-Toro Maria E By Munera Family Trust | DRMA | Common Stock | I | 19.512 | ||||||||
| 2021-08-12 | 3 | Proehl Investment Ventures LLC | DRMA | Common Stock | D | 917.317 | ||||||||
| 2021-08-12 | 3 | HALE DAVID F | DRMA | Common Stock | D | 3.658 | ||||||||
| 2021-08-12 | 3 | HALE DAVID F By Hale BioVentures LLC | DRMA | Common Stock | I | 254.634 | ||||||||
| 2021-08-12 | 3 | HALE DAVID F By Hale Trading Company LP | DRMA | Common Stock | I | 12.195 | ||||||||
| 2021-08-12 | 3 | PROEHL GERALD T By Proehl Investment Ventures LLC | DRMA | Common Stock | I | 917.317 | ||||||||
| 2021-08-12 | 3 | PROEHL GERALD T | DRMA | Common Stock | D | 39.512 | ||||||||
| 2021-08-12 | 3 | INSLEY THOMAS By Insley Family Trust | DRMA | Common Stock | I | 9.756 | ||||||||
| 2021-08-12 | 3 | Nardo Christopher J. | DRMA | Common Stock | D | 25.121 | ||||||||
| 2021-08-12 | 3 | WIERENGA WENDELL | DRMA | Common Stock | D | 4.878 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
